Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential
Allogeneic hematopoietic stem cell transplantation is the main curative therapy for many hematologic malignancies. Its potential relies on graft-versus-tumor effects which associate with graft-versus-host disease. Mesenchymal stromal cells (MSCs) possess immunomodulatory properties that make them at...
Saved in:
Main Authors: | Jeffery J. Auletta (Author), Elizabeth A. Zale (Author), Jean F. Welter (Author), Luis A. Solchaga (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential Role of Quorum Sensing in Clonal Growth and Subsequent Expansion of Bone Marrow Stromal Cell Strains in Culture
by: Maurizio Alimandi, et al.
Published: (2019) -
To Breathe or Not to Breathe: The Role of Oxygen in Bone Marrow-Derived Mesenchymal Stromal Cell Senescence
by: Dhir Niren Gala, et al.
Published: (2021) -
The Effects of Hypoxia on the Immune-Modulatory Properties of Bone Marrow-Derived Mesenchymal Stromal Cells
by: Zsolt Fábián
Published: (2019) -
Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders
by: Noriko Sugino, et al.
Published: (2017) -
What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?
by: R. N. Bárcia, et al.
Published: (2015)